The corresponding relative risk reduction is rather dependent on the tumor biology than on the nodal status and extent of illness [62].In the INSEMA research – a prospectively randomized research comparing SLNE vs. no SLNE in clients with early invasive breast cancer (≤ 5 cm, cN0) and breast-conserving therapy – facts onMany updates of th